Patent: 7,485,704
✉ Email this page to a colleague
Summary for Patent: 7,485,704
Title: | Reducing protein A leaching during protein A affinity chromatography |
Abstract: | A method for reducing leaching of protein A during protein A affinity chromatography is described which involves reducing temperature or pH of, or by adding one or more protease inhibitors to, a composition that is subjected to protein A affinity chromatography. |
Inventor(s): | Fahrner; Robert L. (San Mateo, CA), Laverdiere; Amy (San Francisco, CA), McDonald; Paul J. (San Francisco, CA), O\'Leary; Rhona M. (San Francisco, CA) |
Assignee: | Genentech, Inc. (South San Francisco, CA) |
Application Number: | 10/877,532 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,485,704 |
Patent Claims: | see list of patent claims |
Details for Patent 7,485,704
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2039-02-26 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2039-02-26 |
Genentech, Inc. | HERCEPTIN HYLECTA | trastuzumab and hyaluronidase-oysk | Injection | 761106 | 02/28/2019 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |